NorthX Biologics achieves milestone GMP certification to manufacture vididencel
Mendus’ lead cell therapy product for acute and chronic myeloid leukemias Matfors, Sweden, 12 01 2025. NorthX Biologics, a leading CDMO and Swedish national innovation hub for advanced biologics, and ...